Babao Dan alleviates gut immune and microbiota disorders while impacting the TLR4/MyD88/NF-?B pathway to attenuate 5-Fluorouracil-induced intestinal injury

被引:41
|
作者
Huang, Bin [1 ,2 ,3 ]
Gui, Mengxuan [2 ]
An, Honglin [3 ]
Shen, Jiayu [3 ]
Ye, Feimin [2 ]
Ni, Zhuona [1 ]
Zhan, Hanzhang [3 ]
Che, Li [4 ]
Lai, Zhicheng [4 ]
Zeng, Jiahan [4 ]
Peng, Jun [1 ,2 ,3 ]
Lin, Jiumao [1 ,2 ,3 ]
机构
[1] Fujian Univ Tradit Chinese Med, Acad Integrat Med, 1 Qiuyang Rd, Fuzhou 350122, Fujian, Peoples R China
[2] Fujian Univ Tradit Chinese Med, Fujian Key Lab Integrat Med Geriatr, Fuzhou 350122, Fujian, Peoples R China
[3] Fujian Univ Tradit Chinese Med, Key Lab Integrat Med Fujian Prov Univ, Fuzhou 350122, Fujian, Peoples R China
[4] Xiamen Tradit Chinese Med Co Ltd, Xiamen 361100, Peoples R China
关键词
Babao Dan; 5-fluorouracil; Intestinal injury; Immune response; Gut microbiota disorder; TLR4/MyD88/NF-kB pathway;
D O I
10.1016/j.biopha.2023.115387
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Adjuvant chemotherapy based on 5-fluorouracil (5-FU), such as FOLFOX, is suggested as a treatment for gastrointestinal cancer. Yet, intestinal damage continues to be a prevalent side effect for which there are no practical prevention measures. We investigated whether Babao Dan (BBD), a Traditional Chinese Medicine, protects against intestinal damage induced by 5-FU by controlling immune response and gut microbiota. 5-FU was injected intraperitoneally to establish the mice model, then 250 mg/kg BBD was gavaged for five days straight. 5-FU led to marked weight loss, diarrhea, fecal blood, and histopathologic intestinal damage. Admin-istration of BBD reduced these symptoms, inhibited proinflammatory cytokine (IL-6, IL-1(i, IFN-& gamma;, TNF-a) secretion, and upregulated the ratio of CD3(+) T cells and the CD4(+)/CD8(+) ratio. According to 16S rRNA sequencing, BBD dramatically repaired the disruption of the gut microbiota caused in a time-dependent way, and increased the Firmicutes/Bacteroidetes (F/B) ratio. Transcriptomic results showed that the mechanism is mainly concentrated on the NF-xB pathway, and we found that BBD reduced the concentration of LPS in the fecal suspension and serum, and inhibited TLR4/MyD88/NF-xB pathway activation. Furthermore, at the genus level on the fifth day, BBD upregulated the abundance of unidentified_Corynebacteriaceae, Aerococcus, Blautia, Jeotga-licoccus, Odoribacter, Roseburia, Rikenella, Intestinimonas, unidentified_Lachnospiraceae, Enterorhabdus, Ruminiclos-tridium, and downregulated the abundance of Bacteroides, Parabacteroides, Parasutterella, Erysipelatoclostridium, which were highly correlated with intestinal injury or the TLR4/MyD88/NF-xB pathway. In conclusion, we established a network involving 5-FU, BBD, the immune response, gut microbiota, and key pathways to explain the pharmacology of oral BBD in preventing 5-FU-induced intestinal injury.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Tacrolimus alleviates LPS-induced AKI by inhibiting TLR4/MyD88/NF-κB signalling in mice
    Hu, Xueqing
    Zhou, Wenqian
    Wu, Shun
    Wang, Rui
    Luan, Zhiyong
    Geng, Xin
    Xu, Na
    Zhang, Zhaoyong
    Ruan, Zhenmin
    Wang, Zenghui
    Li, Furong
    Yu, Chen
    Ren, Hongqi
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (02) : 507 - 514
  • [22] Exogenous Administration of PACAP Alleviates Traumatic Brain Injury in Rats through a Mechanism Involving the TLR4/MyD88/NF-κB Pathway
    Mao, Shan-Shan
    Hua, Rong
    Zhao, Xiao-Ping
    Qin, Xia
    Sun, Zhen-Quan
    Zhang, Yang
    Wu, Yu-Qing
    Jia, Meng-Xing
    Cao, Jun-Li
    Zhang, Yong-Mei
    JOURNAL OF NEUROTRAUMA, 2012, 29 (10) : 1941 - 1959
  • [23] TACI Ig Fusion Protein Inhibits TLR4/MyD88/NF-κB Pathway Alleviates Renal Injury in IgA Nephropathy Rats
    Sun, Jianhua
    Cheng, Yue
    Zhang, Wei
    Chen, Peng
    Chen, Xinnan
    Wang, Caili
    Li, Zengyan
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2024, 18 (06) : 326 - 336
  • [24] Gut Microbiota Disorders Promote Inflammation and Aggravate Spinal Cord Injury Through the TLR4/MyD88 Signaling Pathway
    Rong, Zijie
    Huang, Yuliang
    Cai, Honghua
    Chen, Min
    Wang, Hao
    Liu, Guihua
    Zhang, Zhiwen
    Wu, Jiawen
    FRONTIERS IN NUTRITION, 2021, 8
  • [25] Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling
    Yang, Jing
    Wu, Youping
    Xu, Yan
    Jia, Ji
    Xi, Wenbin
    Deng, Hui
    Tu, Weifeng
    JOURNAL OF SURGICAL RESEARCH, 2021, 260 : 350 - 358
  • [26] Hua-Feng-Dan Alleviates LPS-induced Neuroinflammation by Inhibiting the TLR4/Myd88/NF-κB Pathway: Integrating Network Pharmacology and Experimental Validation
    Zhang, Zehan
    Pei, Yuying
    Zheng, Yuxiao
    Liu, Ying
    Guo, Yixuan
    He, Yanhui
    Cheng, Fafeng
    Wang, Xueqian
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (28) : 2229 - 2243
  • [27] Salvianic Acid A Alleviates Atherosclerosis in Rats by Down-regulating TLR4/MyD88/NF-?B Signal Pathway
    Lin, Jing
    Hu, Xinyi
    Feng, Zhao
    Ke, Yun
    Fu, Haoyun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (08): : 1743 - 1748
  • [28] Novel compound FLZ alleviates rotenoneinduced Parkinson disease model by suppressing TLR4/MyD88/NF-κB pathway through microbiota-gut-brain axis
    ZHAO Zhe
    LI Fang-yuan
    NING Jing-wen
    BAO Xiu-qi
    ZHANG Dan
    中国药理学与毒理学杂志, 2021, 35 (09) : 657 - 657
  • [29] Jianpi Yangxue Qufeng compound alleviates atopic dermatitis via TLR4/MyD88/NF-κB signaling pathway
    Yang, Xuesong
    Wang, Zhimin
    Huang, Hong
    Luo, Guangyun
    Cong, Lin
    Yang, Jianting
    Ye, Jianzhou
    HELIYON, 2024, 10 (01)
  • [30] Isovitexin alleviates acute gouty arthritis in rats by inhibiting inflammation via the TLR4/MyD88/NF-κB pathway
    Sun, Xiujiang
    Li, Peng
    Qu, Xiaoyi
    Liu, Wenguang
    PHARMACEUTICAL BIOLOGY, 2021, 59 (01) : 1326 - 1333